DSM Sinochem Pharmaceuticals launches Rosuvastatin in Western Europe

| By | API, Drug Manufacturing, Generics
0
976

DSM Sinochem Pharmaceuticals (DSP), a global leader in sustainable antibiotics, next-generation statins and anti-fungals, has successfully launched its fully backward integrated, generic Rosuvastatin drug product in multiple Western European countries. The successful launch will be extended to additional countries prior to the end of January, among which is the Netherlands.

After being one of the first companies globally to receive a Certificate of suitability of Monographs of the European Pharmacopoeia (CEP) in early 2016 for Rosuvastatin API, DSP again proves to be a frontrunner by being one of the first to launch Rosuvastatin drug products in Western Europe using its in-house produced API.

Statins are currently the most prescribed drug class globally for high cholesterol and cardiovascular diseases and are among the top selling drugs worldwide. Rosuvastatin is used for reducing high cholesterol and preventing cardiovascular disease, which is the number one cause of death worldwide.

With the successful launch of the Rosuvastatin finished dosage formulation, on top of the earlier successful launch of DSP’s beta lactam drug products, and the upcoming launch of Atorvastatin in Europe by summer 2018, the company is quickly expanding its drug product portfolio.

CEO, Karl Rotthier: “I am proud that our company, together with our partners, is among the first worldwide to launch a generic Rosuvastatin finished dosage formulation in Western Europe upon patent expiration; after being one of the first to offer the Rosuvastatin API under CEP. This shows our dedication to excellence and our aspiration to continue to be an industry leader”.

DSP develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Headquartered in Singapore, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico.

SOURCE: globenewswire
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.